Jobs / United States / Astrazeneca Pharmaceuticals Lp
Director, Global Commercial, HER2-ADC
Astrazeneca Pharmaceuticals Lp · 🇺🇸 US - Gaithersburg - MD
Sponsorship verdict
Sponsorship possible
One solid signal, not two — worth applying, and worth asking about sponsorship early.
- Employer is on a government sponsor recordThe US Department of Labor certified 99 H-1B/E-3 labor condition applications for this employer between Oct 2025 and Jun 2026 (latest Jun 2026) — the step every H-1B hire needs first. USCIS also records 31 H-1B approvals in FY2023. Source: LCA disclosure data (US Department of Labor (OFLC)).
- The posting doesn’t mention sponsorshipSilence isn’t a refusal — ask the recruiter before investing much time.
- No salary bar for this routeH-1B has no fixed salary bar: the employer must pay at least the prevailing wage for the role and area. Cap-subject employers enter a lottery weighted by wage level. Source: https://www.federalregister.gov/documents/2025/12/29/2025-23853/weighted-selection-process-for-registrants-and-petitioners-seeking-to-file-cap-subject-h-1b, rules effective 2026-02-27.
- What Astrazeneca Pharmaceuticals Lp paid sponsored hires in similar roles1 certified filing for “Global Product Teams Finance Director, R&D Finance” (Financial Managers) in MD: $196k–$196k, median $196k. Source: US Department of Labor LCA disclosure data (Oct 2025 – Jun 2026).
- Confirmed live todayWhen a source last listed this job as open.
US H-1B: cap-subject employers enter a lottery weighted by wage level — Level I gets 1 entry, Level IV gets 4 (DHS projected selection odds ≈15% at Level I to ≈61% at Level IV). Universities and non-profit research employers are cap-exempt. The $100,000 fee for new petitions from abroad is currently blocked by a court order (appeal pending).
A verdict summarises public evidence; it is not legal advice and never a guarantee — the employer and the immigration authority decide. Sign in to factor in where you can already work.
Or apply yourself on the official page →
Sponsor Radar — Astrazeneca Pharmaceuticals Lp
The US Department of Labor certified 99 H-1B/E-3 labor condition applications for this employer between Oct 2025 and Jun 2026 (latest Jun 2026) — the step every H-1B hire needs first. USCIS also records 31 H-1B approvals in FY2023. Source: LCA disclosure data (US Department of Labor (OFLC)).
Past sponsorship or register membership never guarantees sponsorship for this vacancy or for you. Full Sponsor Radar for Astrazeneca Pharmaceuticals Lp →
About the role
At AstraZeneca, we are changing the way cancer is treated through science, innovation, and a deep commitment to patients. Our ambition in Oncology is bold: to redefine cancer care, transform outcomes, and bring life-changing medicines to people around the world. As one of the fastest-growing areas of our business, Oncology combines a world-class pipeline, market-leading brands, and a relentless focus on scientific advancement. Joining this team means working at the forefront of one of the most dynamic and meaningful areas in healthcare. We are looking for a Director, Global Commercial, HER2-ADC to join our Global Oncology Franchise Team in Gaithersburg, MD. This is a high-impact global role for an experienced commercial leader whose strongest asset is brand strategy and who thrives in shaping growth beyond a single indication. You will help define how HER2 ADC evolves across tumor types, lead pan-tumor initiatives, shape above-brand strategy, and influence the commercial choices that will shape the brand’s future. You will partner closely with global indication leads, cross-functional colleagues, regional leads and markets. Who you are: The ideal candidate combines strategic thinking with strong execution discipline and will play a central role in shaping the brand’s long-term commercial direction. This role is particularly well suited to someone who is energized by enterprise-level brand strategy and skilled at bringing diverse stakeholders together around a shared ambition. What you will do: Working across the organization, you will translate scientific opportunities, customer insights, and evolving market dynamics into clear strategic choices that drive sustainable growth and improve outcomes for patients. Key accountabilities Lifecycle and future planning • Lead competitive readiness efforts around emerging threats, monitoring the fast-evolving landscape across indications and translating developments into actionable commercial implications. • Play a key role in developing cross-functional lifecycle strategies to maximize the brand’s value throughout its lifecycle and prepare for the transition to post-exclusivity competition. • Develop key strategic presentations for leadership Above-indication strategy and brand evolution • Drive key elements of the above-indication Brand Strategy Plan, developing strategic content and building alignment across a broad cross-functional network (Market Access, Medical, Diagnostics, regional leads). • Ensure seamless execution of key cross-indication initiatives and asset delivery • Shape the evolution of the brand positioning and narrative, to solidify leadership in a rapidly evolving oncology landscape. Market and external expert engagement • Design and implement an innovative market engagement model, leveraging new technologies to enable ongoing dialogue with markets and accelerate the sharing and adoption of best practices across countries. • Optimize engagement with key external experts across indications, ensuring insights are systematically captured, synthesized, and translated into commercial priorities and actions. Essential skills and experience • Bachelor's degree in a relevant field, preferably in a scientific or business discipline. • 5+ years of experience in the pharmaceutical and/or healthcare industry across brand marketing, sales, market research or analytics, strategic planning, or related commercial roles. • Strong marketing experience, including brand strategy, positioning, messaging, segmentation, targeting, agency management and annual planning. • Experience in oncology marketing, with global launch or lifecycle management experience preferred. • Demonstrated ability to translate complex scientific and market information i